Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease

Anne Tsampalieros; Anne M Griffiths; Nick Barrowman; David R Mack

doi:10.1016/j.jpeds.2011.04.028

Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease

J Pediatr. 2011 Aug;159(2):340-2. doi: 10.1016/j.jpeds.2011.04.028. Epub 2011 Jun 8.

Authors

Anne Tsampalieros¹, Anne M Griffiths, Nick Barrowman, David R Mack

Affiliation

¹ Department of Pediatrics, University of Ottawa and Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada.

PMID: 21645909
DOI: 10.1016/j.jpeds.2011.04.028

Abstract

C-reactive protein (CRP), a marker for inflammation, was evaluated with other routine blood tests in children with newly diagnosed inflammatory bowel disease. Evaluation of CRP level helped identify additional patients found to have inflammatory bowel disease at endoscopy, although a sizeable number of patients with mild ulcerative colitis had a normal CRP level.

Publication types

Comparative Study
Multicenter Study

MeSH terms

Biomarkers / blood
C-Reactive Protein / biosynthesis*
Child
Diagnosis, Differential
Early Diagnosis*
Female
Follow-Up Studies
Humans
Inflammatory Bowel Diseases / blood
Inflammatory Bowel Diseases / diagnosis*
Male
Retrospective Studies
Severity of Illness Index

Substances

Biomarkers
C-Reactive Protein